Quoin Pharmaceuticals, Ltd. Sponsored ADR QNRX
6.43
0.05
0.78%
as of 25 Sep
- Market cap
- $12.8M
- P/E
- 0.0×
Follow QNRX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.76 | 2.87 | 3.61 | 1.04 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.98 | 2.75 | 4.17 | 1.35 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.59 | 0.97 | 1.16 | 0.56 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.06 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.11) | (1.72) | (4.71) | (3.78) | |
Cash per Share |
3.81 | 4.96 | 17.55 | 9.20 | |
Shareholders Equity per Share |
1.39 | 3.10 | 12.28 | (2.06) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.39 | 3.10 | 12.28 | (2.06) | |
Free Cash Flow |
(3.14) | (4.87) | (5.03) | (2.23) | |
Working Capital |
5.02 | 9.99 | 14.46 | 0.25 | |
Net Current Asset Value |
3.60 | 8.41 | 12.74 | (1.62) | |
| Other line items | |||||
Quick Ratio |
1.63 | 2.63 | 3.38 | 0.94 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.11) | (1.72) | (4.71) | (3.78) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
1.99 | 1.21 | 1.08 | 1.04 | |
Average Assets |
10.44 | 14.32 | 18.05 | 8.91 | |
Average Common Equity |
3.24 | 7.35 | 11.16 | 2.11 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates